Koyfin Home > Directory > Health Care > Amedisys Inc > EBITDA Margin

Amedisys Inc EBITDA Margin Chart (AMED)

Amedisys Inc annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Amedisys Inc EBITDA Margin for the quarter ending June 06, 2020 was $11m a 2.46% increase of 0m year over year
  • Amedisys Inc EBITDA Margin for the last 12 months ending June 06, 2020 was $10m a 2.73% increase of 0m year over year
  • Amedisys Inc Annual EBITDA Margin for 2019 was $10m a -0.37% decrease of 0m from 2018
  • Amedisys Inc Annual EBITDA Margin for 2018 was $10m a 16.20% increase of 2m from 2017
  • Amedisys Inc Annual EBITDA Margin for 2017 was $8m a 32.39% increase of 3m from 2016
Other Margins & Efficiency Metrics:
  • Amedisys Inc Return on Capital % for the quarter ending December 12, 2018 was 18.37 a 18.84% increase of 3.46 year over year
  • Amedisys Inc Return on Equity % for the quarter ending December 12, 2018 was 23.89 a 14.19% increase of 3.39 year over year
View Chart On Koyfin

Quarterly AMED EBITDA Margin Data

06/2020$11m
03/2020$10m
12/2019$10m
09/2019$10m
06/2019$10m
03/2019$10m
12/2018$9m
09/2018$10m
06/2018$11m
03/2018$10m

Annual AMED EBITDA Margin Data

2019$10m
2018$10m
2017$8m
2016$6m
2015$7m
2014$6m
2013$4m
2012$7m
2011$11m
2010$16m